Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib.
Valabrega G, Capellero S, Cavalloni G, Zaccarello G, Petrelli A, Migliardi G, Milani A, Peraldo-Neia C, Gammaitoni L, Sapino A, Pecchioni C, Moggio A, Giordano S, Aglietta M, Montemurro F. Valabrega G, et al. Breast Cancer Res Treat. 2011 Nov;130(1):29-40. doi: 10.1007/s10549-010-1281-5. Epub 2010 Dec 9. Breast Cancer Res Treat. 2011. PMID: 21153051
TOP2A gene copy gain predicts response of epithelial ovarian cancers to pegylated liposomal doxorubicin: TOP2A as marker of response to PLD in ovarian cancer.
Erriquez J, Becco P, Olivero M, Ponzone R, Maggiorotto F, Ferrero A, Scalzo MS, Canuto EM, Sapino A, Verdun di Cantogno L, Bruna P, Aglietta M, Di Renzo MF, Valabrega G. Erriquez J, et al. Among authors: valabrega g. Gynecol Oncol. 2015 Sep;138(3):627-33. doi: 10.1016/j.ygyno.2015.06.025. Epub 2015 Jun 20. Gynecol Oncol. 2015. PMID: 26100858
Adoptive immunotherapy against ovarian cancer.
Mittica G, Capellero S, Genta S, Cagnazzo C, Aglietta M, Sangiolo D, Valabrega G. Mittica G, et al. Among authors: valabrega g. J Ovarian Res. 2016 May 17;9(1):30. doi: 10.1186/s13048-016-0236-9. J Ovarian Res. 2016. PMID: 27188274 Free PMC article. Review.
Androgen receptor status predicts development of brain metastases in ovarian cancers.
Mittica G, Senetta R, Scotto G, Aglietta M, Maggiorotto F, Ghisoni E, Genta S, Boldorini R, Manini C, Morra I, Buosi R, Sapino A, Cassoni P, Valabrega G. Mittica G, et al. Among authors: valabrega g. Oncotarget. 2017 Jun 20;8(25):41143-41153. doi: 10.18632/oncotarget.17068. Oncotarget. 2017. PMID: 28467804 Free PMC article.
Reprogramming T-cells for adoptive immunotherapy of ovarian cancer.
Genta S, Ghisoni E, Giannone G, Mittica G, Valabrega G. Genta S, et al. Among authors: valabrega g. Expert Opin Biol Ther. 2018 Apr;18(4):359-367. doi: 10.1080/14712598.2018.1425679. Epub 2018 Jan 10. Expert Opin Biol Ther. 2018. PMID: 29307234 Review.
A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two- centers experience.
Ghisoni E, Katsaros D, Maggiorotto F, Aglietta M, Vaira M, De Simone M, Mittica G, Giannone G, Robella M, Genta S, Lucchino F, Marocco F, Borella F, Valabrega G, Ponzone R. Ghisoni E, et al. Among authors: valabrega g. J Ovarian Res. 2018 May 30;11(1):42. doi: 10.1186/s13048-018-0415-y. J Ovarian Res. 2018. PMID: 29843747 Free PMC article.
127 results